Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Langlois, Michel R, Chapman, M John, Cobbaert, Christa, Mora, Samia, Remaley, Alan T, Ros, Emilio, Watts, Gerald F, Borén, Jan +15 more·2018·Clinical Chemistry
DOI 10.1373/clinchem.2018.287037

Cited by (259)

Items 201–259 of 259

  1. A comparative analysis of direct LDL measurement and calculated LDL: Assessing accuracy and clinical implications
    Nita Sahi, Nikita A Pandya, Richa Bharatkumar Modi · 2024 · International Journal of Advanced Biochemistry Research
  2. Lipids, Lipoproteins, and Cardiovascular Outcomes
    Alexander P. Sakers, Reed Mszar, Daniel E. Soffer · 2024 · Contemporary cardiology
  3. Reduction of myocardial lipid content assessed by H1 magnetic resonance spectroscopy in dyslipidemic patients after statins
    Eslam Elsayed Mohamed Elmenyawy, Hend Gamal Abu-El Fadl, Hesham Mohammed Fathy Waly, Abdul Razek Abdul Lateef Maaty, Hanaa Mahmoud Mohammad Abdelaziz · 2024 · The Egyptian Journal of Radiology and Nuclear Medicine
  4. Leveraging free-text diagnoses to identify patients with diabetes mellitus, obesity or dyslipidaemia – a cross-sectional study in a large Swiss primary care database
    Donika Balaj, Jakob Martin Burgstaller, Audrey Wallnöfer, Katja Weiss, Oliver Senn, Thomas Johannes Rosemann, Thomas Grischott, Stefan Markun · 2025 · Swiss Medical Weekly
  5. Impact of fasting duration on LDL cholesterol concentrations estimated by the Friedewald, Martin-Hopkins, and Sampson/NIH equations
    Şerif Ercan, Ali Manav · 2025 · Biochemia Medica
  6. Association of APOB (rs515135) and PCSK9 (rs505151) gene polymorphisms with CAD in the Indian population
    Ale Eba, Syed Tasleem Raza, Irshad Ahmad Wani, Bashir Ahmad, Mohammad Abbas, Zeba Siddiqi, Sanchita Srivastava, Farzana Mahdi · 2025 · Biomarkers in Medicine
  7. Examining barriers and facilitators to testing lipoprotein(a): Understanding at-risk individual and clinician perspectives
    Shoshana H. Bardach, Skye M. Chernichky-Karcher, Allison Hawke, Diane Elaine MacDougall, Katherine A. Wilemon, Laurence S. Sperling · 2025 · Journal of clinical lipidology
  8. Efficacy and safety of proprotein convertase subtilisin/kexin type 9 inhibitors for adults with familial hypercholesterolemia: A network meta-analysis
    Weiwei Ding, Lirui Sun, Yun Shi, Lei Tian · 2025 · International Journal of Cardiology Cardiovascular Risk and Prevention
  9. 2025 Egyptian guidelines for the management of dyslipidemia
    Ashraf Reda, Hesham Taha, Hala Mahfouz Badran, Hazem Khamis, Sherif Kamal, Ahmed Shawky Elserafy, Muhammad Hasan Dawoud, Ahmed A. Elamragy, Ahmed Bendary, Mirna Mamdouh Shaker · 2026 · The Egyptian Heart Journal
  10. Importance and Management of Non–High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment
    Richard Charles O’Brien, Lourdes Ella G. Santos, Brian Tomlinson, Zanariah Binti Hussein, Soo Lim, Hapizah Mohd Nawawi, Hean Yee Ong, SILKI Silki, Sidartawan Soegondo, Ta‐Chen Su et al. · 2026 · JACC Asia
  11. Poor Performance of LDL-Cholesterol Equations versus Beta Quantification in a Very Large Cohort of Patients with Dyslipidemia
    Martine Paquette, George Thanassoulis, Mark H. Sherman, David W. Blank, Alexis Wilfrid Baass · 2026 · Clinical Chemistry
  12. Update on Investigation and Management of Dyslipidaemias and Cardiovascular Disease Risk
    Kofi Antwi, Ahai Luvai, Paul F. DOWNIE, Ayoob Ghani, Megan Maple, Wycliffe Mbagaya · 2026 · British Journal of Hospital Medicine
  13. Assessment of Associations Between Arterial Mechanical Properties and Biochemical Blood Markers for Early Detection of Atherosclerosis
    Kristina Kööts, Kristjan Pilt, Madis Sepa, Marika Pikta, Ivo Fridolin, Kalju Meigas, Margus Viigimaa · 2020 · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
  14. Evaluation of atherogenic lipoprotein-cholesterol to HDL cholesterol ratio as a prognostic test for ST-segment elevation myocardial infarction
    Jiayong Li, Wenjun Xu, Zhe Guang Zhou, Ru-Lin Zhang, Ting Sun, Hao Xu, Jun Wu · 2021 · International Journal of Medical Sciences
  15. Increased risk of hypercholesterolemia in a French and Lebanese population due to an interaction between rs2569190 in CD14 and gender
    Saïd El Shamieh, Ali Salami, Maria G. Stathopoulou, Pia Chedid, Sophie Visvikis‐Siest · 2020 · Clinica Chimica Acta
  16. Current Concepts in Management of Lipid Abnormalities in Patients With Coronary Artery Disease
    Kunal Mahajan, K. Sarat Chandra · 2020 · Indian Journal of Clinical Cardiology
  17. Searching for the ideal LDL cholesterol estimating formula
    Remo H.M. Furtado · 2021 · International Journal of Cardiology
  18. Colesterol de LDL: los tiempos están cambiando
    M. John Chapman, Philippe Giral, Patrice Thérond · 2021 · Redalyc (Universidad Autónoma del Estado de México)
  19. Prävention kardiovaskulärer Erkrankungen durch medikamentöse LDL-Cholesterin-Senkung
    Corinna Lebherz · 2018 · Kardiologie up2date
  20. Genetic disorders of lipoprotein metabolism
    Deepak Bhatnagar, Jonathan D. Schofield, Handrean Soran · 2019 · Elsevier eBooks
  21. ESC-Leitlinie Dyslipidämien: die 10 Kernbotschaften
    Kai Toussaint, Claudia Brückner · 2020 · MMW - Fortschritte der Medizin
  22. How ApoB Measurements Could Improve Prevention of Cardiovascular Disease
    Allan D. Sniderman · 2020 · Contemporary cardiology
  23. Survey on lipid diagnostics in Italy from the Working Group on Myocardial Markers (GdS MM) of the Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL): results and recommendations for reporting
    Massimiliano Luca Manno, Piero Cappelletti, Marco Moretti, Elisabetta Stenner, Francesca Veneziani, Maria Aurora Burgio, Martina Di Pietro, Margherita Morandini, Giulio Marino, Jessica VIOLA et al. · 2021 · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
  24. Incorporation of biochemical parameters and diagnostic algorithms in the laboratory computer system for the early detection of lipid abnormalities from the lipid units
    Teresa Arrobas Velilla, Elena Bonet Estruch, Jessica Roa Garrido, Manuel Romero Jiménez, Gema María Varó Sánchez, Ignacio Vázquez Rico · 2021 · Clínica e Investigación en Arteriosclerosis (English Edition)
  25. Hypertriglyzeridämie
    Martin Merkel · 2020 · Aktuelle Kardiologie
  26. Assessment of Risks of Cardiovascular Diseases among Leprosy Patients Settlement at Ossiomo-Ogan Rehabilitation Center, Edo State, Nigeria
    Grace Umahi-Ottah, Babatunde Ishola Gabriel Adejumo, Laurel Imose Oyakhilome, Uchechukwu Dimkpa, Simon Uzor, Oladimeji Nasiru Abdulrahman, Noreen Ebelechukwu Agbapuonwu, Anslem Onochie Ajugwo, Musiliu Adewale Oyenike · 2021 · Health
  27. Nuclear Magnetic Resonance (NMR) Spectroscopy on the Effect of PCSK9 Inhibitor on Lipoprotein Particles in Patients With Acute Coronary Syndromes(ACS)
    tingting li, Hongliang Cong, yingyi zhang · 2020
  28. Racionalidad científica para la evolución de las metas de LDL-c
    Francisco Javier Guerrero-Martínez · 2021 · Cardiovascular and Metabolic Science
  29. Fettstoffwechselstörungen
    Baptist Gallwitz · 2020 · Gastroenterologie up2date
  30. Comparative Assessment of LDL-C and VLDL-C Estimation in Familial Combined Hyperlipidemia using Sampson’s, Martin’s and Friedewald’s Equations.
    Arsenio Vargas‐Vázquez, Omar Yaxmehen Bello‐Chavolla, Neftali Eduardo Antonio‐Villa, Roopa Mehta, Ivette Cruz‐Bautista, Carlos Alberto Aguilar-Salinas · 2021 · Research Square
  31. Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: Data from the DISGEN-LIPID study
    Pedro Marques da Silva, Carlos Aguíar, João Morais · 2019 · Revista Portuguesa de Cardiologia (English Edition)
  32. Fettstoffwechsel
    Karl Otfried Schwab, Jürgen Doerfer · 2022 · Springer eBooks
  33. Apolipoprotein B in Primary Prevention: Ready for Time Prime?
    Renato Quispe, Bibin T. Varghese, Seth Shay Martin · 2022 · Contemporary cardiology
  34. Hypertriglyceridaemia: a commentary
    Aidan Ryan, William G Simpson, Patrick J. Twomey · 2022 · Journal of Clinical Pathology
  35. Efeito do exercício físico sobre o metabolismo e função da HDL em indivíduos de diferentes faixas etárias
    Pedro Gabriel Senger Braga · 2022
  36. Measurement of Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Low-Density Lipoprotein Particle Concentration
    Samia Mora, Seth Shay Martin · 2023 · Elsevier eBooks
  37. Comparison of existing methods of low-density lipoprotein cholesterol estimation in patients with type 2 diabetes mellitus
    Gerald Gui Ren Sng, You Liang Khoo, Khung Keong Yeo, Wann Jia Loh, Tar Choon Aw, Joan Joo Ching Khoo, Lynette Mei Yi Lee, Gilbert Choon Seng Tan, Hong Chang Tan, Yong Mong Bee · 2023 · Annals of the Academy of Medicine Singapore
  38. Discordance of Circulating Non-HDL Cholesterol with LDL Cholesterol Concerning Long-Term Prognosis in Statin-Treated Individuals with Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting Undergoing Percutaneous Coronary Intervention
    Chuang Li, Kuizheng He, Yixing Yang, Kuibao Li, Mulei Chen, Lefeng Wang, Yuanfeng Gao, Xiaorong Xu · 2023 · Reviews in Cardiovascular Medicine
  39. Bringing Human Serum Lipidomics to the Forefront of Clinical Practice: Two Clinical Diagnosis Success Stories
    Núria Amigó, Pablo Ortiz Betes · 2023 · Springer eBooks
  40. Comparison Of Low-Density Lipoprotein Cholesterol (Ldl-C), Atherogenic Index In Plasma (Aip) And Apolipoprotein B/Apolipoprotein A1 Ratio In Patients Sent For Routine Lipid Profile Testing At Biochemistry Laboratory - Kenyatta National Hospital
    Peter Kibet Kiptim, Rahab Wangari Kariuki, Damaris Kimonge · 2023 · medRxiv
  41. The Association Between apolipoprotein B and Risk of Cardiovascular Disease：Mendelian randomization analysis
    Pengli Chen, Ziwei Song, Dewang Ran, Lili Li · 2024 · Research Square
  42. Labordiagnostik von Fettstoffwechselstörungen
    Winfried März, Hubert Scharnagl, Marcus Edi Kleber, Günther Silbernagel, Matthias Nauck, Dirk Müller‐Wieland, Arnold von Eckardstein · 2024 · Diabetes aktuell
  43. Apolipoprotein and peripheral artery disease: Mendelian randomization analysis
    Chen-Xin Wan, Yu-Shu Gong, Tao Xu · 2024 · Vascular
  44. Evaluation of Different Formulas for Calculation of LDL Cholesterol in Northern Indian Population
    Patel Seema · 2022 · Journal of Applied Biochemistry & Laboratory Medicine
  45. Triglyceride Levels Should be Lowered to Reduce Cardiovascular Risk
    Pablo Corral, Augusto Lavalle Cobo · 2025
  46. “SES”, “SESS”, or “SVESS” approaches for patients with myocardial infarction
    Nicola Ferri · 2025 · International Journal of Cardiology
  47. Comparative performance of machine learning vs classical formulas for LDL-cholesterol calculation
    Salomón Martín Pérez, Remo Suppi, Teresa Arrobas Velilla, Francisco de Borja Téllez Hernández, Antonio León‐Justel · 2025 · Clínica e Investigación en Arteriosclerosis (English Edition)
  48. From LDL to apolipoprotein B: shifting the lens on cardiovascular risk
    Sterenn Guillerme, Jean-François Perregaux, Antonio Gallo · 2026 · European Journal of Preventive Cardiology
  49. Improving secondary prevention after transient ischaemic attack (TIA) or ischaemic stroke
    Marion Boulanger · 2019
  50. Dosage of lipoproteins for risk management according to guidelines
    Christophe Bonnin, Caroline Fourgeaud, Guillaume Mahé, Khalil Ezzaki, Marc Gras, François Xavier Himpens, Romain Jacquet, Lina Khider, Tristan Mirault, J.N. Poggi et al. · 2026 · Vascular Diseases
  51. Association of the apolipoproteins with retinal arteriosclerosis in a health examination population
    Xinghe Sun, Lijuan Guo, Hui Lv, Xian Zhang, Chenghao Wu, Xiaohui Liu · 2026 · Frontiers in Cardiovascular Medicine
  52. Standardization Challenges and Breakthroughs in Apolipoprotein B Detection: From Immunoassays to LC‐MS/MS
    Anqi Pan, Haijian Zhao, Jing Wang, Jiangtao Zhang, Hao Zheng, C J Zhang, Wenxiang Chen, Tianjiao Zhang · 2026 · Mass Spectrometry Reviews
  53. Österreichischer Lipidkonsensus 2026
    Florian Kronenberg, Florian Höllerl, Helmut Brath, Gersina Rega‐Kaun, Susanne Greber‐Platzer, Christoph Weiser, Dominic P Klein, Nikolaus Riesenhuber, Christoph J. Binder, Johanna Maria Brix et al. · 2026 · Wiener klinische Wochenschrift
  54. Nuevas tendencias en biomarcadores de dislipidemia y evaluación de riesgo cardiovascular: avances y perspectivas
    Leslie Juliana Padilla Cancelado, Paula Andrea Páez Rozo, Jennifer Carolina Gutiérrez · 2026 · Revista Med
  55. High resolution lipoprotein subfraction profiling identifies obesity associated distributional changes in LDL and HDL subfractions and particle ratios
    Novia Minaee, Reika Masuda, Philipp Nitschke, Drew Hall, Jennie Hui, Michael L Hunter, Leon A Flicker, Graeme J. Hankey, Osvaldo P. Almeida, Dick C. Chan et al. · 2026 · International Journal of Obesity
  56. Screening Signals of Reference-Defined Metabolic Syndrome Using HbA1c and LDL Cholesterol: An Explainable Machine Learning Study
    Osman Demir · 2026 · Diagnostics
  57. Apolipoprotein B in cardiovascular risk assessment: beyond traditional lipid markers
    Lingling Li, Yixuan Feng, Xiaoya Li, Zongliang Yu, Changxin Sun, Lanqing Hu, Kaidong Zhou, Xinyi Liu, Yongfang Yuan, Liang Li et al. · 2026 · Frontiers in Cardiovascular Medicine
  58. Serum Lipid Profile, Atherogenic Indices, and Systemic Inflammatory Markers in Retinal Vein Occlusion: A Retrospective Case–Control Study
    Nurcan Gürsoy, Şenay Deniz · 2026 · Journal of Ophthalmology
  59. Association of Spinal Epidural Lipomatosis With Systemic Lipid Metabolism in Patients With Lumbar Spinal Stenosis: A Propensity Score-Matched Study
    Bolu Zhang, Qingshuang Zhou, Chao Zhong, Sinian Wang, 赵青华, Hu Zongshan, Bin Wang, Yong Qiu, Zezhang Zhu, Xu Sun · 2026 · The Spine Journal